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ABSTRACT The molecular basis of atherosclerosis is
associated with excessive proliferation of vascular cells.
Previous studies have suggested an inverse correlation
between the expression of the growth suppressor
p27Kip1 (p27) and cellular proliferation within human
atherosclerotic tissue. However, no causal link between
diminished p27 expression and atherogenesis has been
established. We investigated the effect of p27 inactiva-
tion on diet-induced atherogenesis. We find that p27-
deficient mice challenged with a high-fat diet for 1
month remain normocholesterolemic and have essen-
tially no visible atheromas. However, when generated in
an apolipoprotein E-null genetic background that leads
to severe hypercholesterolemia in response to the
atherogenic diet, deletion of p27 enhances arterial cell
proliferation (;fourfold) and accelerates atherogene-
sis (;sixfold) compared with apolipoprotein E-defi-
cient mice with an intact p27 gene. Analysis of apoli-
poprotein E-null mice bearing only one p27 allele
inactivated reveals that a moderate decrease in p27 pro-
tein expression in the setting of hypercholesterolemia is
sufficient to predispose to atherogenesis. Thus, our study
establishes a molecular link between decreased p27 pro-
tein expression and atherogenesis in hypercholester-
olemic animals.—Dı´ez-Juan, A., Andre´s, V. The growth
suppressor p27Kip1 protects against diet-induced athero-
sclerosis. FASEB J. 15, 1989–1995 (2001)
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Tight control of cellular proliferation is essential
throughout embryonic development and adulthood in
higher eukaryotes. Progression through the mamma-
lian cell cycle requires the activation of cyclin-depen-
dent kinases (CDKs) through their association with
regulatory subunits called cyclins (1). Different CDK/
cyclin holoenzymes are activated at specific phases of
the cell cycle. Active CDK/cyclin complexes phosphor-
ylate the retinoblastoma gene product and the related
pocket proteins p107 and p130 from mid-G1 to mitosis,
which in turn regulate the activity of members of the
E2F family of transcription factors (2, 3). Cell prolifer-
ation in mammals is negatively regulated by CDK
inhibitory proteins (CKIs), which associate with and
inhibit the activity of CDK/cyclin holoenzymes (1, 4).
CKIs of the CIP/KIP family (p21, p27, and p57) bind to
and inactivate a broad range of CDKs, whereas mem-
bers of the INK4 family (p15, p16, p18, p19) are
specific for CDK4- and CDK6-containing holoenzymes.
Coronary artery disease (i. e., atherosclerosis, postan-
gioplasty restenosis, and vein-graft failure) is the lead-
ing cause of mortality and morbidity in the Western
population (5). The molecular basis of these disorders
involves dysregulated growth of vascular smooth muscle
cells (VSMCs) and macrophages (6, 7). Accumulating
evidence implicates the growth suppressor p27 as an
important regulator of the phenotypic response of
VSMCs to mitogenic and hypertrophic stimuli, both in
vitro and in vivo. First, up-regulation of p27 may limit
the growth of VSMCs at late time points after balloon
angioplasty (8, 9). Consistent with this possibility, over-
expression of p27 efficiently blocked mitogen- and
c-fos-dependent induction of cyclin A promoter activity
in cultured VSMCs (8, 10), and adenovirus-mediated
overexpression of p27 inhibited vascular occlusive le-
sion formation in balloon-injured arteries (8, 11).
Moreover, p27 is hypothesized to serve as a molecular
switch that determines whether VSMCs undergo hyper-
trophic or hyperplastic growth (12, 13). Regarding the
role of p27 on hematopoietic cells, it has been sug-
gested that suppression of p27 enhances hematopoietic
progenitor cell proliferation and facilitates early devel-
opment of promyeloid cells into macrophages (14, 15).
Immunohistochemical analysis have suggested an
inverse correlation between p27 expression and prolif-
eration of macrophages and VSMCs within human
atherosclerotic tissue (9, 16). However, a causal link
between p27 and the pathogenesis of atherosclerosis
has not been established. In the present study, we
investigated the effect of p27 inactivation on diet-
induced atherosclerosis. Our study establishes a molec-
ular link between decreased p27 protein expression
and atherosclerosis in hypercholesterolemic animals.
MATERIALS AND METHODS
Mice, genotyping, and diets
Mice deficient for apolipoprotein E (apoE) (17) (mixed
C57BL/63129Sv background; gift from J. Osada, Zaragoza,
1 Correspondence: Instituto de Biomedicina de Valencia
(IBV-CSIC), C/Jaime Roig, 11, 46010 Valencia, Spain. E-mail:
vandres@ibv.csic.es
19890892-6638/01/0015-1989 © FASEB
Spain) and p27 (18) (C57BL/6 background; gift from M.
Serrano, Madrid, Spain) were mated and the double het-
erozygous F1 offspring were intercrossed. F2 mice were
genotyped by PCR analysis and brother-sister mating of p271/
2apoE2/2 mice was performed to obtain p271/1apoE2/2,
p271/2apoE2/2, and p272/2apoE2/2 mice. After weaning,
mice were maintained on a low-fat standard diet (2.8% fat,
Panlab, Barcelona, Spain). At 2 months of age, mice received
for 1 month an atherogenic diet containing 15.8% fat, 1.25%
cholesterol, and 0.5% sodium cholate (TD 88051; Harlan/
Teklad, Madison, WI). Blood was withdrawn before and after
the high-fat diet to measure plasma cholesterol and triglycer-
ide levels using enzymatic procedures (Sigma, St. Louis, MO).
Quantification of atherosclerosis, histomorphometry,
and immunohistochemistry
Fat-fed mice were killed and their aortas were fixed in situ
with 4% paraformaldehyde. After carefully removing the
adventitia, the aorta was excised, fixation was continued
overnight, and vessels were opened longitudinally and stained
with Oil Red O solution (0.2% in 80% MetOH) (Sigma).
Specimens were pinned onto a flat surface and photographed
with a Sony DKC-CM30 camera (Tokyo, Japan) mounted on
a Zeiss Stemmi 2000-C dissecting scope (Jena, Germany). To
determine the extent of atherosclerosis in the aortic arch
region (from the aortic root up to ;1.5 mm beyond the left
subclavian artery), digital images were analyzed by computer-
assisted quantitative morphometry using Sigma Scan Pro v5.0
(Jandel Scientific, San Rafael, CA). For each animal, the area
stained with Oil Red O was divided by total investigated area
(average ;14 mm2). Differences in lesion area between males
and females were not significant, so data from both sexes
were included in these analyses.
The intima-to-media ratio was determined as an indepen-
dent measure of atheroma formation. In another set of
animals, the heart and the proximal aorta were fixed with
100% methanol. Specimens were paraffin-embedded and
mounted in a Microm microtome (Heidelberg, Germany).
Once the three valve cusps were reached, sections throughout
the first ;2 mm of the ascending aorta were discarded. Then,
;25 consecutive sections (5 mm thickness) were taken from
two or three regions of the aortic arch separated by ;60 mm.
Three cross sections from each region were stained with
hematoxylin/eosin. Images were captured with the digital
camera mounted on a Zeiss Axiolab stereomicroscope and
the area occupied by atherosclerotic lesions (intima) and the
area of the media were determined by computer-assisted
quantitative morphometry to calculate the intima-to-media
ratio. The results for each animal were calculated by averag-
ing all independent values.
Histological examination of methanol fixed cross sections
included quantification of cellularity and fibrous cap thick-
ness in the lesions of p272/2apoE2/2 and p271/1apoE2/2
mice. Lesion cellularity was estimated by dividing the number
of cells per mm2 of plaque. The relative fibrous cap thickness
was calculated by dividing fibrous cap thickness at the center
of the lesion by lesion thickness (19) in 66 fibrous caps from
5 mice of each genotype.
Methanol-fixed cross sections were also analyzed by immu-
nohistochemistry. Proliferation was estimated with anti-PCNA
antibodies (1/50, sc-7907, Santa Cruz Biotechnology, Santa
Cruz, CA), a biotin/streptavidin-peroxidase detection system
(Signet Laboratories, Dedham, MA), and 0.05% (w/v) 3,39-
diaminobenzidine tetrahydrochloride dihydrate substrate
(Vector Laboratories; Burlingame, CA). For each mouse,
PCNA-positive cells were counted in at least three sections
from different regions of the aortic arch and results were
averaged. Macrophages were identified using anti-F4/80 an-
tibody (1/10, MCAP497, Serotec, Raleigh, NC) after pretreat-
ment with 0.25% trypsin (3 min, 37°C). Immunocomplexes
were detected using biotinylated secondary antibody (sc-2041,
Santa Cruz Biotechnology) and alkaline phosphatase-conju-
gated Streptavidin (Biogenex, San Ramon, CA). VSMCs were
identified with alkaline phosphatase-conjugated anti-smooth
muscle a-actin (SMa-actin) antibody (1/200, a-5691, Sigma).
Alkaline phosphatase activity was detected with Fast Red
(Sigma). VSMC content in atherosclerotic lesions was deter-
mined morphometrically by dividing the SMa-actin-positive
area by total plaque area.
Statistical analysis
Results are reported as mean 6 se. In experiments with two
groups, differences were evaluated using a 2-tailed, unpaired
t test. Analysis involving more than two groups were done
using ANOVA and Fisher’s post hoc test (Statview, SAS
institute, Cary, NC).
Western blot analysis
For each genotype, snap-frozen arteries from three animals
were pooled and lysed in ice-cold 50 mM Tris-HCl buffer (pH
7.5) containing 1% Triton X-100, 150 mM NaCl, 1 mM DTT,
and protease inhibitor Complete Mini mixture (Roche,
Mannheim, Germany) using an Ultraturrax T25 basic (IKA
Labortechnik, Staufen, Germany). Western blot analysis was
performed as described previously (8) using the following
primary antibodies (Santa Cruz Biotechnology): rabbit poly-
clonal anti-p27 (1/200, sc-776) and mouse monoclonal anti-
tubulin (1/200, sc-3035). The relative intensity of protein
bands was determined by densitometry.
RESULTS
Effect of p27 inactivation on diet-induced
atherosclerosis
We investigated the effect of inactivating p27 on the
atherogenic process induced by a high-fat diet. Since as
a species the mouse is highly resistant to atherosclerosis
(20), we performed our studies in apoE-deficient mice,
which develop atherosclerotic lesions resembling those
observed in humans (17, 21). By intercrossing mice
deficient for p27 and apoE, we generated apoE-null
mice bearing various levels of p27 (p271/1apoE2/2,
p271/2apoE2/2, and p272/2apoE2/2). Our
studies also included p27-null mice with an intact apoE
gene (p272/2apoE1/1). We first examined the
plasma triglyceride and cholesterol levels in mice fed
either a control diet or a high-fat diet (Fig. 1). All mice
maintained on control chow exhibited normolipi-
demia. Likewise, p272/2apoE1/1 animals chal-
lenged with the high-fat diet for 1 month remained
normolipidemic. In contrast, fat-fed apoE-deficient
mice developed comparable hyperlipidemia regardless
of their status for p27. Thus, in agreement with previ-
ous studies (17, 21), mice with an intact apoE gene did
not display hyperlipidemia when exposed to an athero-
genic diet. Moreover, reduction or ablation of p27 did
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not affect the hyperlipidemic response normally ob-
served in fat-fed apoE-null mice.
We next analyzed atherogenesis in fat-fed mice by
examining whole arteries stained with Oil Red O (Fig.
2A). Based on gross morphological inspection, p27-null
mice with intact apoE revealed essentially no visible
atheromas. As expected, p271/1apoE2/2 mice de-
veloped atherosclerosis in the aorta, which prevailed
within the aortic arch. All double nullizygous p272/2
apoE2/2 mice revealed augmented atherosclerosis
compared with p271/1apoE2/2 mice, and p27 het-
erozygous mice with inactivated apoE (p271/2apoE2/2)
appeared to have an intermediate phenotype. To rig-
orously determine the extent of atherosclerosis in these
mice, we performed computer-assisted quantitative
morphometry of Oil Red O-stained arteries. When
compared with p271/1apoE2/2 mice (n512), the
area of lesions positive for Oil Red O was enhanced by
;threefold in p271/2apoE2/2 mice (n510, P,0.002)
and by ;sixfold in p272/2apoE2/2 mice (n510,
P,0.0001) (Fig. 2B). The above findings were con-
firmed by examination of arterial cross sections stained
with hematoxylin/eosin (Fig. 3A). These analyses dis-
closed an intima-to-media ratio of 0.25 6 0.02 in
p271/1apoE2/2 mice (n58), 0.43 6 0.06 in p271/2
apoE2/2 mice (n55), and 0.96 6 0.20 in p272/2
apoE2/2 mice (n58; P,0.0015 vs. p271/1apoE2/2;
P,0.025 vs. p271/2apoE2/2) (Fig. 3B). Collectively,
these findings indicate that p27 disruption alone is not
sufficient to induce atherosclerosis in mice with an
intact apoE gene, which remain normolipidemic de-
spite the exposure to a high-fat diet. However, the
severity of atherosclerosis in fat-fed apoE-null mice,
which develop acute hyperlipidemia, is incrementally
exacerbated by inactivation of one or two p27 alleles. As
expected, immunoblot analysis revealed the absence of
p27 expression in the aorta of p272/2apoE2/2 mice
(Fig. 2C). Densitometric analysis of two independent
blots revealed an average ;42% decrease of p27 pro-
tein expression in the aorta of p271/2apoE2/2
compared with p271/1apoE2/2 mice (Fig. 2C).
Thus, reduction or ablation of p27 expression en-
hances atherosclerosis in hyperlipidemic mice.
Histological and immunohistochemical
characterization of atherosclerotic lesions in
p271/1apoE2/2 and p272/2apoE2/2 mice
We then examined the effect of p27 inactivation on the
cellular composition of atherosclerotic lesions. Histo-
morphometric analysis revealed higher cellularity in
the lesions of p272/2apoE2/2 mice compared with
p271/1apoE2/2 mice (9.760.1 cells mm-2 vs.
6.660.6 cells mm-2, respectively, n57, P,0.05) (Fig. 4A,
C). In both groups, immunohistochemical analysis us-
ing rat monoclonal F4/80 antibody demonstrated the
presence of macrophages throughout the intimal le-
sions (Fig. 5C and data not shown). We also examined
the presence of VSMCs using a mouse monoclonal
anti-SMa-actin antibody (Fig. 4B). As indicated by the
ratio SMa-actin-positive area/total plaque area, VSMCs
were more abundant within the lesions of p272/2
apoE2/2 mice (0.4760.05 vs. 0.2260.08 in p271/1
apoE2/2 mice, n57, P,0.04) (Fig. 4D). Moreover,
relative fibrous cap thickness was greater in p272/
2apoE2/2 mice compared with control animals
(0.3560.02 vs. 0.1860.02, n566 fibrous caps, P,0.0001
(Fig. 4A, E). Thus, lesions in the p272/2apoE2/2
mice appeared more advanced, consistent with acceler-
ated atherogenesis in these animals.
We reasoned that enhanced cell proliferation might
contribute to augmented atherosclerosis and hypercel-
lularity in the lesions of p272/2apoE2/2 mice. To
test this possibility, we performed immunohistochemi-
cal analysis using specific antibodies for proliferating
cell nuclear antigen (PCNA) as a measure of cell
proliferation (22–25). Quantitative analysis revealed
that PCNA immunoreactivity in the aortic arch of
p272/2apoE2/2 mice was significantly higher than
in p271/1apoE2/2 mice, both in the media (fivefold
increase, P,0.0015) and within atherosclerotic lesions
(threefold increase, P,0.035) (Fig. 5A). To investigate
Figure 1. Plasma lipid levels in mice fed control chow or a
cholesterol-rich diet. Results represent the mean 6 se of the
indicated number of animals. Gender distribution is indi-
cated in parentheses. Open bars: 2-month-old mice fed
control chow. Solid bars: 3-month-old mice fed a cholesterol-
rich diet for 1 month. Differences in plasma lipid levels
among all groups were evaluated using ANOVA and Fisher’s
PLSD post hoc test. Only comparisons between mice of the
same genotype are shown (control vs. cholesterol-rich diet:
*P,0.0003; **P,0.0001); NS, not significant (P.0.05). Re-
gardless of their status for p27, all fat-fed apoE-deficient mice
developed comparable hyperlipidemia (P.0.05).
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the identity of proliferating cells, we performed immu-
nohistochemical analysis. By double immunohisto-
chemistry, we found that the majority of PCNA-positive
cells in the media of p271/1apoE2/2 and p272/2
apoE2/2 mice were also SMa-actin immunoreactive
(Fig. 5B). In contrast, colocalization of PCNA and
SMa-actin was rarely observed within atheromatous
plaques (Fig. 5B), where PCNA immunoreactivity was
seen mainly in macrophage-rich areas (Fig. 5C).
DISCUSSION
Ablation of p27 in the mouse leads to enhanced
growth, multiorgan hyperplasia, and increased pituitary
tumors (18, 26, 27). This phenotype has been attrib-
uted to increased cell proliferation, most clearly in
tissues that express higher levels of p27. It is accepted
that p27 functions as a tumor suppressor gene (28),
and p27 also safeguards against excessive cell prolifer-
ation during glomerulonephritis and ureteral obstruc-
tion (29). Given that excessive proliferation of macro-
phages and VSMCs underlies the atherogenic process
(6), we sought to investigate the effect of p27 inactiva-
tion on diet-induced atherosclerosis. These studies
were performed in apoE-null mice, a well-characterized
animal model of atherosclerosis that recapitulates im-
portant features of the human disease (17, 21). Our
results demonstrate that a moderate (;42%) reduction
in p27 protein expression in the aorta of hyperlipid-
emic p271/2apoE2/2 mice is sufficient to augment
diet-induced atherosclerosis compared with p271/1
apoE2/2 mice, and this phenotype is exacerbated in
apoE-null mice lacking both p27 alleles (p272/2
apoE2/2). Fero et al. (30) have demonstrated that
p27 is haplo-insufficient for tumor suppression. These
authors showed that p27 nullizygous mice are predis-
posed to tumor formation induced by ionizing radia-
tion or a chemical carcinogen, and p27 heterozygous
mice showed intermediate rates of tumorigenesis. Col-
lectively, these studies indicate that a moderate reduc-
tion in p27 expression might be sufficient to increase
the risk of cancer and atherosclerosis. Indeed, p27
Figure 2. Inactivation of p27 in fat-fed apoE-null mice aug-
ments the area of Oil Red O-stained atheromatous plaques.
Mice with the indicated genotypes were challenged with a
high-fat diet for 1 month. The aorta was dissected out and
stained with Oil Red O. A) Representative examples of the
aortic arch (red regions correspond to atherosclerotic le-
sions). Atheromatous plaques were essentially negligible in
p272/2apoE1/1 mice. Grossly visible atherosclerotic
plaques were evident in all groups of fat-fed apoE-null mice,
which predominated within the aortic arch. B) Extent of
atherosclerosis determined by computer-assisted quantitative
morphometry. Results represent the ratio Oil Red O positive
area/total area (average total area ;14 mm2) and are ex-
pressed as fold-increase vs. p271/1apoE2/2 mice (51).
Gender distribution for each group was 5 males/7 females
(p271/1apoE2/2), 6 males/4 females (p271/2apoE2/2),
and 5 males/5 females (p272/2apoE2/2). Statistical anal-
ysis: *P , 0.002; **P , 0.0001, vs. p271/1apoE2/2; †P ,
0.0001 vs. p271/2apoE2/2. C) Immunoblot analysis of cell
lysates prepared from the aorta of fat-fed apoE-null mice with
the indicated genotype for p27. Primary antibodies were
anti-p27 (top) and anti-tubulin (bottom). Relative to p271/1
apoE2/2 mice, aortic p27 expression in p271/2apoE2/2
was 0.58 6 0.01 (n52 densitometric analysis normalized by
tubulin content).
Figure 3. Inactivation of p27 in fat-fed apoE-null mice in-
creases the intima-to-media ratio within the aortic arch. Mice
with the indicated genotypes were challenged with a high-fat
diet for 1 month. A) Representative examples of cross sections
from the aortic arch stained with hematoxylin and eosin.
Original magnification: 253. B) Quantification of the intima-
to-media ratio in cross sections of the aortic arch corrobo-
rated the findings with Oil Red-O-stained arteries (see Fig.
2B). Gender distribution for each group was 5 males/3
females (p271/1apoE2/2); 3 males/2 females (p271/2
apoE2/2), and 4 males/4 females (p272/2apoE2/2).
Statistical analysis (vs. p272/2apoE2/2): *P , 0.0015;
**P , 0.025.
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expression is frequently down-regulated in human tu-
mors and a reduced level of p27 correlates with poor
prognosis (28, 31–33).
Our results suggest that enhanced atherosclerosis in
fat-fed p272/2apoE2/2 mice results, at least in part,
from increased VSMC and macrophage proliferation.
Consistent with our findings, previous studies have
shown that p27 is a potent inhibitor of VSMC prolifer-
ation (8, 9) and that suppression of p27 expression
might promote the proliferation of hematopoietic pro-
genitor cells and their differentiation into macro-
phages (14, 15). Augmented cell proliferation by dis-
ruption of the growth suppressor p53 has been also
associated with enhanced atherogenesis in fat-fed apoE-
deficient mice (34). Given that the CKI p21 has been
detected in human atherosclerotic tissue (9), it will be
instructive to test the effect of p21 inactivation on
atherogenesis.
Excessive VSMC proliferation is also thought to con-
tribute to restenosis postangioplasty (6, 7). It is hypoth-
esized that induction of endogenous p21 and p27 may
limit the hyperplastic growth of VSMCs at late time
points after angioplasty in rat and porcine arteries (8, 9,
35). Conversely, p53 inactivation after cytomegalovirus
infection may increase the risk of human coronary
restenosis (36, 37). Ectopic overexpression of these
growth suppressors has proved efficient at limiting
neointimal lesion development after experimental an-
gioplasty. These include adenovirus-mediated (8, 11)
and rapamycin-dependent (38) overexpression of p27,
adenovirus-mediated overexpression of p21 (35, 39,
40), and p53 arterial gene transfer (41). Thus, human
studies are warranted to test the efficacy of p27, p21,
and p53 overexpression for the inhibition of restenosis
after percutaneous interventions.
It is noteworthy that inactivation of either p27 (this
study) or p53 (34) by itself is not sufficient to promote
atherogenesis in mice challenged with an atherogenic
diet for 4–10 wk. Fat-fed p272/2 and p532/2 mice
remained normocholesterolemic at the end of the
experimental protocol. However, when generated in an
apoE-null genetic background that leads to severe
hypercholesterolemia in response to the atherogenic
diet, ablation of either p27 or p53 accelerated the
underlying atherogenic process triggered by hypercho-
lesterolemia. These findings support the notion that
excessive vascular cell proliferation is subsidiary to
injury to the vessel wall initiated by atherogenic stimuli
(i. e., hypercholesterolemia) rather than the cause of
this process (6). Another example of a synergistic
pathological response involving p27 concerns tumor
Figure 4. Disruption of p27 enhances lesion cellularity, VSMC
content and relative fibrous cap thickness. Cross sections
from the aortic arch were stained with hematoxylin (A) or
immunostained with anti-SMa-actin antibody (B). Arrow-
heads indicate the internal elastic lamina. Original magnifi-
cation: 1003. Morphometric analysis was performed to quan-
tify lesion cellularity in hematoxylin-stained specimens (C)
and the area of lesion containing SMa-actin-immunoreactive
cells (D) (n57 mice each group). E) Relative fibrous cap
thickness was calculated by dividing fibrous cap thickness at the
center of the lesion by lesion thickness. Results represent the
mean 6 se of n 5 66 fibrous caps from 5 animals in each group.
Figure 5. Disruption of p27 enhances arterial cell prolifera-
tion in fat-fed mice. Cross sections from the aortic arch were
analyzed by immunohistochemistry. A) Quantification of the
number of PCNA-positive cells in the media and intimal
lesions of p271/1apoE2/2 (n57, 4 males/3 females) and
p272/2apoE2/2 (n56, 3 males/3 females) mice. Results
represent the average number of PCNA-immunoreactive cells
per cross section. Note that proliferating cells, as indicated by
PCNA immunoreactivity, were more abundant in p272/2
apoE2/2 mice compared with p271/1apoE2/2 mice,
both in the media (P,0.0015) and within lesions (P,0.035).
B) Double immunostaining using anti-PCNA and anti-SMa-
actin antibodies (brown nuclear and red cytoplasmic staining,
respectively) revealed abundant proliferating VSMCs within
the media. However, colocalization of both antigens was
scarce within atheromatous plaques. C) Adjacent cross sec-
tions of a p272/2apoE2/2 mouse immunostained with
anti-PCNA antibody and macrophage-specific anti-F4/80 an-
tibody. Note that PCNA-immunoreactive areas within the
lesion correspond generally to macrophage-rich regions. Ar-
rowheads indicate the internal elastic lamina. Original mag-
nification: 2003 (B) and 1003 (C).
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development. Indeed, spontaneous tumorigenesis in
p27-deficient mice appears to be limited to pituitary
adenomas (18, 26, 27). However, when challenged with
tumorigenic agents (i. e., chemical carcinogens or
ionizing radiation), p27-null mice display increased
tumor predisposition in multiple tissues (30). These
studies suggest that p27 safeguards against the hyper-
proliferative response triggered by a variety of patho-
logical stimuli.
By the use of genetically modified mice, we have
shown that reduced p27 protein expression increases
the severity of atherosclerosis induced by hypercholes-
terolemia. Whether diminished p27 expression may be
a common event during atherogenesis remains to be
established. Tanner et al. (9) found that p27 protein
was abundantly expressed in intimal and medial VSMCs
of nonatherosclerotic human coronary arteries. Like-
wise, p27 expression was commonly observed in regions
of coronary atherosclerotic plaques not undergoing
proliferation and was absent within proliferating
plaque cells. As indicated by double-labeling tech-
niques, the majority of cells expressing p27 in early and
advanced human atheromas were VSMCs and macro-
phages. Ihling et al. (16) also reported p27 immunore-
activity in human atherosclerotic coronary and carotid
artery specimens, which localized to nuclei of macro-
phages, VSMCs, T lymphocytes, and endothelial cells.
These authors provided evidence that TGF-b1 present
in human atherosclerotic tissue may mediate its growth-
suppressive function through p27. Bearing in mind
these expression studies and our results demonstrating
a causal link between diminished p27 expression and
atherogenesis, it is appropriate to consider the role of
p27 in an atherosclerotic plaque in influencing both
its initial response to mitogenic stimuli and its pro-
gression to more advanced stages. Hence, future
studies in animal models and human tissue should
thoroughly investigate the temporal and spatial pat-
tern of expression of p27 during atherogenesis and
elucidate molecular mechanisms underlying the reg-
ulation of p27 expression in vascular cells. Such
information would find application not only in vas-
cular proliferative diseases, but also in human neo-
plastic disorders in which tumor progression and
patient mortality might be associated with reduced
p27 expression (28, 31–33).
We thank J. Roberts, M. Serrano, and J. Osada for provid-
ing p27-null and apoE-null mice. We are also grateful to R.
Arroyo for technical help, J. Cubells for animal care, and
colleagues for critical reading of the manuscript. Work in the
laboratory of V.A. is supported in part by grants from the
Spanish Direccio´n General de Educacio´n Superior e Investi-
gacio´n Cientı´fica (PM97–0136, 1FD97–1035-C02–02).
REFERENCES
1. Morgan, D. O. (1995) Principles of CDK regulation. Nature
(London) 374, 131–134
2. Weinberg, R. A. (1996) E2F and cell proliferation: a world
turned upside down. Cell 85, 457–459
3. Lavia, P., and Jansen-Durr, P. (1999) E2F target genes and
cell-cycle checkpoint control. Bioessays 21, 221–230
4. Elledge, S. J., and Harper, J. W. (1994) Cdk inhibitors: on the
threshold of checkpoints and development. Curr. Opin. Cell Biol.
6, 847–852
5. Tunstall-Pedoe, H., Kuulasmaa, K., Mahonen, M., Tolonen, H.,
Ruokokoski, E., and Amouyel, P. (1999) Contribution of trends
in survival and coronary-event rates to changes in coronary heart
disease mortality: 10-year results from 37 WHO MONICA
project populations. Monitoring trends and determinants in
cardiovascular disease. Lancet 353, 1547–1557
6. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspec-
tive for the 1990s. Nature (London) 362, 801–809
7. Libby, P., and Tanaka, H. (1997) The molecular basis of
restenosis. Prog. Cardiovasc. Dis. 40, 97–106
8. Chen, D., Krasinski, K., Chen, D., Sylvester, A., Chen, J., Nisen,
P. D., and Andre´s, V. (1997) Downregulation of cyclin-depen-
dent kinase 2 activity and cyclin A promoter activity in vascular
smooth muscle cells by p27Kip1, an inhibitor of neointima
formation in the rat carotid artery. J. Clin. Invest. 99, 2334–2341
9. Tanner, F. C., Yang, Z.-Y., Duckers, E., Gordon, D., Nabel, G. J.,
and Nabel, E. G. (1998) Expression of cyclin-dependent kinase
inhibitors in vascular disease. Circ. Res. 82, 396–403
10. Sylvester, A. M., Chen, D., Krasinski, K., and Andre´s, V. (1998)
Role of c-fos and E2F in the induction of cyclin A transcription
and vascular smooth muscle cell proliferation. J. Clin. Invest.
101, 940–948
11. Tanner, F. C., Boehm, M., Akyu¨rek, L. M., San, H., Yang, Z.-Y.,
Tashiro, J., Nabel, G. J., and Nabel, E. G. (2000) Differential
effects of the cyclin-dependent kinase inhibitors p27Kip1,
p21Cip1, and p16Ink4 on vascular smooth muscle cell prolifera-
tion. Circulation 101, 2022–2025
12. Braun-Dullaeus, R. C., Mann, M. J., Ziegler, A., von der Leyen,
H. E., and Dzau, V. J. (1999) A novel role for the cyclin-
dependent kinase inhibitor p27Kip1 in angiotensin II-stimulated
vascular smooth muscle cell hypertrophy. J. Clin. Invest. 104,
815–823
13. Servant, M. J., Coulombe, P., Turgeon, B., and Meloche, S.
(2000) Differential regulation of p27Kip1 expression by mito-
genic and hypertrophic factors: involvement of transcriptional
and posttranscriptional mechanisms. J. Cell Biol. 148, 543–556
14. Liu, Q., VanHoy, R. W., Zhou, J. H., Dantzer, R., Freund, G. G.,
and Kelley, K. W. (1999) Elevated cyclin E levels, inactive
retinoblastoma protein, and suppression of the p27KIP1 inhibi-
tor characterize early development of promyeloid cells into
macrophages. Mol. Cell. Biol. 19, 6229–6239
15. Cheng, T., Rodrigues, N., Dombkowski, D., Stier, S., and Scad-
den, D. T. (2000) Stem cell repopulation efficiency but not pool
size is governed by p27kip1. Nat. Med. 6, 1235–1240
16. Ihling, C., Technau, K., Gross, V., Schulte-Monting, J., Zeiher,
A. M., and Schaefer, H. E. (1999) Concordant upregulation of
type II-TGF-beta-receptor, the cyclin-dependent kinases inhibi-
tor p27Kip1 and cyclin E in human atherosclerotic tissue: impli-
cations for lesion cellularity. Atherosclerosis 144, 7–14
17. Zhang, S. H., Reddick, R. L., Piedrahita, J. A., and Maeda, N.
(1992) Spontaneous hypercholesterolemia and arterial lesions
in mice lacking apolipoprotein E. Science 258, 468–471
18. Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo,
E., Plyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., Kaush-
ansky, K., and Roberts, J. M. (1996) A syndrome of multiorgan
hyperplasia with features of gigantism, tumorigenesis, and fe-
male sterility in p27Kip1-deficient mice. Cell 85, 733–744
19. Lutgens, E., Gorelik, L., Daemen, M. J., de Muinck, E. D.,
Grewal, I. S., Koteliansky, V. E., and Flavell, R. A. (1999)
Requirement for CD154 in the progression of atherosclerosis.
Nat. Med. 5, 1313–1316
20. Breslow, J. L. (1996) Mouse models of atherosclerosis. Science
272, 685–688
21. Plump, A. S., Smith, J. D., Hayek, T., Aalto-Seta¨la¨, K., Walsh, A.,
Verstuyft, J. G., Rubin, E. M., and Breslow, J. L. (1992) Severe
hypercholesterolemia and atherosclerosis in apolipoprotein E-
deficient mice created by homologous recombination in ES
cells. Cell 71, 343–353
22. Bravo, R., and MacDonald-Bravo, H. (1987) Existence of two
populations of cyclin/proliferating cell nuclear antigen during
the cell cycle: association with DNA replication sites. J. Cell Biol.
105, 1549–1554
1994 Vol. 15 September 2001 DI´EZ-JUAN AND ANDRE´SThe FASEB Journal
23. Galand, P., and Degraef, C. (1989) Cyclin/PCNA immunostain-
ing as an alternative to tritiated thymidine pulse labelling for
marking S phase cells in paraffin sections from animal and
human tissues. Cell Tissue Kinet. 22, 383–392
24. Hall, P., Levison, D., Woods, A., Yu, C.-W., Kellock, D., Watkins,
J., Barnes, D., Gillet, C., Camplejohn, R., Waseem, N., and Lane,
D. (1990) Proliferating cell nuclear antigen (PCNA) immuno-
localization in paraffin sections: an index of cell proliferation
with evidence of deregulated expression in some neoplasms.
J. Pathol. 162, 285–294
25. Kawakita, N., Seki, S., Sakaguchi, S., Yanai, A., Kuroki, T.,
Mizoguchi, Y., Kobayashi, K., and Monna, T. (1992) Analysis of
proliferating hepatocytes using a monoclonal antibody against
proliferating cell nuclear antigen/cyclin in embedded tissues
from various liver diseases fixed in formaldehyde. Am. J. Pathol.
140, 513–520
26. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T.,
Shishido, N., Horii, I., Loh, D. Y., and Nakayama, K. (1996) Mice
lacking p27Kip1 display increased body size, multiple organ
hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85,
707–720
27. Kiyokawa, H., Kineman, R. D., Manova-Todovora, K. O., Soares,
V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C.,
Frohman, L. A., and Koff, A. (1996) Enhanced growth of mice
lacking the cyclin-dependent kinase inhibitor function of
p27Kip1. Cell 85, 721–732
28. Philipp-Staheli, J., Payne, S. R., and Kemp, C. J. (2001) p27Kip1:
regulation and function of a haploinsufficient tumor suppressor
and its misregulation in cancer. Exp. Cell Res. 264, 148–168
29. Ophascharoensuk, V., Fero, M. L., Hughes, J., Roberts, J. M.,
and Shankland, S. J. (1998) The cyclin-dependent kinase inhib-
itor p27Kip1 safeguards against inflammatory injury. Nat. Med. 4,
575–580
30. Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., and Kemp,
C. J. (1998) The murine gene p27Kip1 is haplo-insufficient for
tumour suppression. Nature (London) 396, 177–180
31. Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M.,
Gatti, L. A., Firpo, E. J., Daling, J. R., and Roberts, J. M. (1997)
Expression of cell-cycle regulators p27Kip1 and cyclin E, alone or
in combination, correlate with survival in young breast cancer
patients. Nat. Med. 3, 222–225
32. Catzavelos, C., Bhattacharya, N., Ung, Y. C., Wilson, J. A.,
Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I.,
Kapusta, L., Franssen, E., Pritchard, K. I., and Slingerland, J. M.
(1997) Decreased levels of the cell-cycle inhibitor p27Kip1 pro-
tein: prognostic implications in primary breast cancer. Nat. Med.
3, 227–230
33. Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentino, M.,
Draetta, G. F., Jessup, J. M., and Pagano, M. (1997) Increased
proteosome-dependent degradation of the cyclin-dependent
kinase inhibitor p27 in aggressive colorectal carcinomas. Nat.
Med. 3, 231–234
34. Guevara, N. V., Kim, H. S., Antonova, E. I., and Chan, L. (1999)
The absence of p53 accelerates atherosclerosis by increasing cell
proliferation in vivo. Nat. Med. 5(3), 335–339
35. Yang, Z.-Y., Simari, R. D., Perkins, N. D., San, H., Gordon, D.,
Nabel, G. J., and Nabel, E. G. (1996) Role of p21 cyclin-
dependent kinase inhibitor in limiting intimal cell proliferation
in response to arterial injury. Proc. Natl. Acad. Sci. USA 93,
7905–7910
36. Speir, E., Modali, R., and Huang, E.-S. (1994) Potential role of
human cytomegalovirus and p53 interaction in coronary reste-
nosis. Science 265, 391–394
37. Zhou, Y. F., Leon, M. B., Waclawiw, M. A., Popma, J. J., Yu, Z. X.,
Finkel, T., and Epstein, S. E. (1996) Association between prior
cytomegalovirus infection and the risk of restenosis after coro-
nary atherectomy. N. Engl. J. Med. 335, 624–630
38. Gallo, R., Padurean, A., Jayaraman, T., Marx, S., Rogue, M.,
Adelman, S., Chesebro, J., Fallon, J., Fuster, V., Marks, A., and
Badimon, J. J. (1999) Inhibition of intimal thickening after
balloon angioplasty in porcine coronary arteries by targeting
regulators of the cell cycle. Circulation 99, 2164–2170
39. Chang, M. W., Barr, E., Lu, M. M., Barton, K., and Leiden, J. M.
(1995) Adenovirus-mediated over-expression of the cyclin/cy-
clin-dependent kinase inhibitor, p21 inhibits vascular smooth
muscle cell proliferation and neointima formation in the rat
carotid artery model of balloon angioplasty. J. Clin. Invest. 96,
2260–2268
40. Ueno, H., Masuda, S., SNishio, S., Li, J. J., Yamamoto, H., and
Takeshita, A. (1997) Adenovirus-mediated transfer of cyclin-
dependent kinase inhibitor p21 suppresses neointimal forma-
tion in the balloon-injured rat carotid arteries in vivo. Ann. N.Y.
Acad. Sci. 811, 401–411
41. Yonemitsu, Y., Kaneda, Y., Tanaka, S., Nakashima, Y., Komori,
K., Sugimachi, K., and Sueishi, K. (1998) Transfer of wild-type
p53 gene effectively inhibits vascular smooth muscle cell prolif-
eration in vitro and in vivo. Circ. Res. 82, 147–156
Received for publication February 21, 2001.
Revised for publication May 29, 2001.
1995p27 PROTECTS AGAINST ATHEROSCLEROSIS
